Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medacta : Gets CE Mark For NextARTM Knee, Shoulder and Spine Applications

05/27/2021 | 11:29pm EDT


ę MT Newswires 2021
All news about MEDACTA GROUP SA
04:40aMEDACTA : underscores its continuous Global Commitment with the 1st M.O.R.E. Spi..
PU
07/21MEDACTA : announces the publication of 2020 Sustainability Report
PU
07/20MEDACTA : Lifts 2021 Guidance After 32% Surge in H1 Revenue
MT
07/20MEDACTA : reports 35.4% growth at constant currency of half-year revenue and rev..
PU
07/20EQS-ADHOC : Medacta Group SA reports 35.4% growth -2-
DJ
07/20EQS-ADHOC : Medacta Group SA reports 35.4% growth at constant currency of half-y..
DJ
07/20Medacta Group Sa Reports Unaudited Revenue Results for the First Half Ended J..
CI
07/20Medacta Group SA Revises Revenue Guidance for the Full Year 2021
CI
07/14MEDACTA : Settles Patent Infringement, Contract Violation Case With MicroPort
MT
07/14MEDACTA : Says Initial Reverse Shoulder Arthroplasty Carried Out With NextAR Pro..
MT
More news
Financials
Sales 2021 352 M 416 M 416 M
Net income 2021 53,7 M 63,5 M 63,5 M
Net Debt 2021 63,9 M 75,5 M 75,5 M
P/E ratio 2021 48,0x
Yield 2021 0,53%
Capitalization 2 528 M 2 760 M 2 987 M
EV / Sales 2021 7,36x
EV / Sales 2022 6,48x
Nbr of Employees 1 183
Free-Float 30,5%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 126,40 €
Average target price 103,07 €
Spread / Average Target -18,5%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA44.29%2 760
ABBOTT LABORATORIES9.16%212 366
MEDTRONIC PLC9.33%172 114
BECTON, DICKINSON AND COMPANY-0.32%72 539
HOYA CORPORATION5.22%50 566
ALIGN TECHNOLOGY, INC.18.94%50 298